SSH - SPRINGFIELD INC. — History
CCN 262017 | 3-year financial timeline | COVID resilience: 71/100
🛡️ Public data only — no PHI permitted on this instance.
$24M
Latest Revenue (FY2022)
+11.8%
Revenue CAGR (3yr)
0.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $19M | $23M | $24M | +3.4% | +11.8% |
| Operating Expenses | $20M | $20M | $24M | +17.4% | +10.2% |
| Operating Margin | -2.3% | 12.4% | 0.5% | -95.8% | +0.0% |
| Net Income | $-0M | $3M | $0M | -95.6% | +0.0% |
| Licensed Beds | 44 | 44 | 44 | +0.0% | +0.0% |
| Total Patient Days | 11,809 | 13,873 | 13,470 | -2.9% | +6.8% |
| Medicare Day % | 37% | 31% | 27% | -14.9% | -15.1% |
| Medicaid Day % | 27% | 18% | 18% | -4.0% | -19.8% |
COVID Impact & Recovery
Resilience Score: 71/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +25.0% ($19M → $24M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.8%
This Hospital
+7.6%
State Avg
Latest Margin
0.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $27M | 1.9% |
| FY2024 (proj) | $29M | 3.4% |
| FY2025 (proj) | $31M | 4.8% |